Monday of the First Week in Advent Reading 1 Is

New Post Public Reply Private Reply Replies (0) Message Board
Bible Feed
Monday of the First Week in Advent

Reading 1 Is 4:2-6

On that day,
The branch of the LORD will be luster and glory,
and the fruit of the earth will be honor and splendor
for the survivors of Israel.
He who remains in Zion
and he who is left in Jerusalem
Will be called holy:
every one marked down for life in Jerusalem.
When the LORD washes away
the filth of the daughters of Zion,
And purges Jerusalem’s blood from her midst
with a blast of searing judgment,
Then will the LORD create,
over the whole site of Mount Zion
and over her place of assembly,
A smoking cloud by day
and a light of flaming fire by night.
For over all, the LORD’s glory will be shelter and protection:
shade from the parching heat of day,
refuge and cover from storm and rain.

Responsorial Psalm Ps 122:1-2, 3-4b, 4cd-5, 6-7, 8-9

R. Let us go rejoicing to the house of the Lord.
I rejoiced because they said to me,
“We will go up to the house of the LORD."
And now we have set foot
within your gates, O Jerusalem.
R. Let us go rejoicing to the house of the Lord.
Jerusalem, built as a city
with compact unity.
To it the tribes go up,
the tribes of the LORD.
R. Let us go rejoicing to the house of the Lord.
According to the decree for Israel,
to give thanks to the name of the LORD.
In it are set up judgment seats,
seats for the house of David.
R. Let us go rejoicing to the house of the Lord.
Pray for the peace of Jerusalem!
May those who love you prosper!
May peace be within your walls,
prosperity in your buildings.
R. Let us go rejoicing to the house of the Lord.
Because of my relatives and friends
I will say, “Peace be within you!"
Because of the house of the LORD, our God,
I will pray for your good.
R. Let us go rejoicing to the house of the Lord.

Alleluia See Ps 80:4

R. Alleluia, alleluia.
Come and save us, LORD our God;
let your face shine upon us, that we may be saved.
R. Alleluia, alleluia.

Gospel Mt 8:5-11

When Jesus entered Capernaum,
a centurion approached him and appealed to him, saying,
“Lord, my servant is lying at home paralyzed, suffering dreadfully.”
He said to him, “I will come and cure him.”
The centurion said in reply,
“Lord, I am not worthy to have you enter under my roof;
only say the word and my servant will be healed.
For I too am a man subject to authority,
with soldiers subject to me.
And I say to one, ‘Go,’ and he goes;
and to another, ‘Come here,’ and he comes;
and to my slave, ‘Do this,’ and he does it.”
When Jesus heard this, he was amazed and said to those following him,
“Amen, I say to you, in no one in Israel have I found such faith.
I say to you, many will come from the east and the west,
and will recline with Abraham, Isaac, and Jacob
at the banquet in the Kingdom of heaven.”
- - -
Lectionary for Mass for Use in the Dioceses of the United States, second typical edition, Copyright © 2001, 1998, 1997, 1986, 1970 Confraternity of Christian Doctrine; Psalm refrain © 1968, 1981, 1997, International Committee on English in the Liturgy, Inc. All rights reserved. Neither this work nor any part of it may be reproduced, distributed, performed or displayed in any medium, including electronic or digital, without permission in writing from the copyright owner.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Peptide Therapy Rules Change: Gameday Ups the Ante

Updated Category News Views 110

Gameday Men's Health: Leading the Safe Peptide Charge Finally, we got some regulatory sanity stepping up to the plate with peptides. You see, the FDA's new interim policy is letting state-licensed compounding pharmacies work their magic with peptides, but only under strict medical watch. And Gameday Men's Health sure ain't wasting any time setting up shop in this fresh...

Continue Reading
Markel's Reinsurance Shift with $4.8B Deal: Strategic Move?

Updated Category News Views 100

Weaving Through Complex Insurance Terrain When Markel Insurance pulls a move on the chessboard that involves $4.8 billion in subject reserves, we better pay attention. The insurance bigwig has inked a reinsurance deal with Enstar. This plan, they say, will help them focus more on their specialty insurance game while tidying up the loose ends in their global reinsurance...

Continue Reading
Hollywood Vampires' Limited Art Sparks Las Vegas Buzz

Updated Category News Views 117

A Collaboration to Captivate Art and Rock Enthusiasts When it comes to mixing rock and roll with fine art, Markus Klinko's exclusive photograph featuring the Hollywood Vampires hits the nail on the head. It’s not just an image; it’s a slice of modern rock history immortalized on paper. This new release, a portrait capturing the raw passion of Alice Cooper, Johnny...

Continue Reading
?atwogang Leads Tiltify's Impact Creator Class of 2026

Updated Category News Views 60

Charity Meets Creativity: A New Era Unveiled Who would have thought? Charitable fundraising is no longer just about writing checks. It's about creativity, community, and leveraging tech to drive change. Enter Tiltify's Creator Impact Class of 2026—proof that we're living in a brave new world where internet creators are the kings and queens of giving. ?atwogang Takes...

Continue Reading
Alchemy's Texas Move: Strategic Growth or Gamble?

Updated Category News Views 80

Making a Splash in Texas IT Services Alchemy Technology Group's acquisition of Freeit Data Solutions isn't just another drop in the tech pond; it's a cannonball aimed at shaking up the IT and cybersecurity scenes in Texas. By bringing Freeit's impressive 16-year track record under its wing, Alchemy is flexing its muscles in a region already bustling with IT infrastructure...

Continue Reading
Group 1 Automotive Q3 2026: Profits Soar, Revenues Dip

Updated Category News Views 34

Profits Up, Revenues Down Here's a tale for the books—Group 1 Automotive reports their third quarter results of 2026 and it's a bit like swapping a thunderstorm for a hurricane. Net income from continuing operations stomped on last year's figures, clocking in at a hefty $102.9 million compared to a skimpy $13.1 million. But don't let that fool you, their total revenues...

Continue Reading
Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 49

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Miracle League Marks Two Decades with Big Fundraising Win

Updated Category News Views 66

A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...

Continue Reading
Palmdale Propane Expands with Affordable Gas Buy

Updated Category News Views 50

Propane Power Play in Florida's Market Here's a little tune you don't hear every day: two local businesses tangoing to the beat of expansion without making a public peep about the price. Palmdale Propane, a powerhouse under the Palmdale Oil umbrella, just snapped up Affordable Gas, a local player from Belle Glade, Florida. This acquisition strengthens its grip on the...

Continue Reading
Northeast Indiana Bancorp Shows Solid Third Quarter Gains

Updated Category News Views 47

Holding Steady in a Shaky Market In a market often rocked by turbulence, it seems Northeast Indiana Bancorp, Inc. has found a decent footing to stand on. Announcing their third-quarter results for 2026, they’ve posted net income of $1.991 million, showcasing a neat jump from the $1.793 million in the same period last year. Not bad at all for the parent company of First...

Continue Reading

Top 5 Most Recently Viewed Articles

Boosty Labs Elevates Leadership to Fuel 2025 Vision

Updated Category News Views 170

Boosty Labs Moves Forward with Strategic Leadership Changes Boosty Labs, a prominent name in Blockchain, Bitcoin, and Web3 development, is taking a substantial leap forward. As the company prepares for significant growth, the leadership team has undergone key changes aimed at driving operational excellence and innovation. New Roles for Vitalii Yatskiv and Denys Doronin In...

Continue Reading
Sinclair Inc. Elevates Leadership With Key Promotions

Updated Category News Views 236

Sinclair Inc. Elevates Leadership With Key Promotions BALTIMORE - Sinclair Inc. (NASDAQ: SBGI), a significant force in the media landscape recognized for its local news and sports coverage, with a market capitalization of $963 million, has recently elevated several key executives within its organizational structure and various subsidiaries. These strategic executive...

Continue Reading
Nasus Pharma's IPO: Paving the Way for Innovative Treatments

Updated Category News Views 172

Nasus Pharma Completes Initial Public Offering Nasus Pharma Ltd. (NYSE: NSRX) recently celebrated the successful conclusion of its initial public offering (IPO), marking a significant milestone for the company. This clinical-stage pharmaceutical firm, based in Israel, specializes in developing innovative intranasal products designed for treating emergency medical...

Continue Reading
Discover the Compact Keurig® K-Mini Mate™ Brewer Today

Updated Category News Views 105

Introducing the Keurig® K-Mini Mate™ Brewer The world of coffee brewing has evolved with the introduction of the Keurig® K-Mini Mate™ Brewer. This remarkable machine, available exclusively at Target, marks a significant leap in convenience and taste. Notably small at just 4 inches wide, this brewer is perfect for anyone who values space without wanting to sacrifice...

Continue Reading
Explore Telix Pharmaceuticals' Latest Innovations in Urology

Updated Category News Views 179

Join Telix Pharmaceuticals for a Pioneering Webinar Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX) is excited to extend an invitation to investors for a comprehensive webinar centered on the company’s leading-edge developments in urology. This event will highlight innovative approaches to treating prostate and kidney cancers, showcasing the remarkable potential...

Continue Reading